Sildenafil Citrate Market Trends

  • Report ID: 2582
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Sildenafil Citrate Market Trends

Growth Drivers

  • Prevalence of Erectile Dysfunction: It is estimated that ageing in men increases the risk of erectile dysfunction in them. However it is stated that ED can occur at any age, but most common in older men. ED can be also be caused by heart-related diseases, diabetes, obesity, tobacco and alcohol consumption. According to the WHO, the proportion of world’s population over 60 years is estimated to nearly double from 12% to 22% between 2015 and 2020. Further, it was reported by IHME, that in 2017, 4.7 million deaths globally were caused by obesity and majority of the cases were reported in urban areas of the world where reduced activity and poor diets are attributed to accelerate the rise of it. Ageing population, prevalence of cardiovascular diseases, obesity and high consumption of alcohol and tobacco are factors contributing to increase in the number of ED cases and thus expected to positively impact the sildenafil citrate market.
  • Awareness towards ED by Governments and NGOs: Adult males shy away from the topic of ED in public discussions. Understanding and acceptance about ED and its prevalence among adult males through awareness programs by governments and NGOs is expected to drive the sildenafil citrate market forward.

Challenges

  • Availability of Erectile Dysfunction Alternatives: The availability of alternatives such as Tadalafil (Cialis), Vardenafil (Levitra) and Vardenafil (Staxyn) is expected to negatively impact the sales of sildenafil citrate medication and thus hamper the sildenafil citrate market growth in the coming years.

Sildenafil Citrate Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5.4%

Base Year Market Size (2023)

USD 1.58 billion

Forecast Year Market Size (2036)

USD 3.13 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2582
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of sildenafil citrate is assessed at USD 1.65 billion.

Sildenafil Citrate Market size was valued at USD 1.58 billion in 2023 and is expected to reach USD 3.13 billion by 2036, expanding at around 5.4% CAGR during the forecast period i.e., between 2024-2036.

North America industry is predicted to hold largest revenue share by 2036, propelled by higher number of ED cases in the region.

The major players in the market are Pfizer Inc., Bayer AG, Apricus Biosciences, Inc., Cristália, Aglowmed Pharmaceuticals Ltd., Mylan N.V., VIVUS Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample